Andrew S. Goldstein
Nessuna posizione attualmente
Profilo
Andrew S.
Goldstein formerly worked at Epitope, Inc., as Director & SVP-Product Development in 2010, Virogenomics BioDevelopment, Inc., as Vice President-Product Development from 2001 to 2004, Artielle ImmunoTherapeutics, Inc., as Vice President-Product Development from 2004 to 2009, and TerraLUX, Inc., as Chief Operating Officer.
Mr. Goldstein received his graduate degree from Fordham University, undergraduate degree from Cornell University, and undergraduate degree from the University of Minnesota.
Precedenti posizioni note di Andrew S. Goldstein
| Società | Posizione | Fine |
|---|---|---|
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/12/2009 |
TerraLUX, Inc.
 TerraLUX, Inc. Electrical ProductsProducer Manufacturing TerraLUX, Inc. designs, patents and manufactures innovative LED based lighting products. It also designs and manufactures LED modules for lighting manufacturers, retailers, and designers. The firm's products include LED surface mount retrofit kits, down light retrofit kits and LEDSENSE intelligent controls. The company was founded by Anthony Catalano in 2003 and is headquartered in Longmont, CO. | Direttore operativo | - |
Epitope, Inc.
 Epitope, Inc. Medical SpecialtiesHealth Technology Epitope, Inc, operates through its subsidiaries. The company provides and develops diagnostic tests and devices for the detection of Human immunodeficiency virus (HIV) through its subsidiary. The company's products include OraSure, an oral specimen collection device and EPIblot, a serum-based Western blot confirmatory test kit. The prime customers of the company includes life insurance companies, prison systems, the military, and colleges and universities. The products are marketed in United States, Canada, Europe, Asia, Latin America and other countries. It is located in Beaverton, OR. | Corporate Officer/Principal | - |
Virogenomics BioDevelopment, Inc.
 Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | Corporate Officer/Principal | 01/01/2004 |
Formazione di Andrew S. Goldstein
| Cornell University | Undergraduate Degree |
| Fordham University | Graduate Degree |
| University of Minnesota | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | Health Technology |
Epitope, Inc.
Epitope, Inc. Medical SpecialtiesHealth Technology Epitope, Inc, operates through its subsidiaries. The company provides and develops diagnostic tests and devices for the detection of Human immunodeficiency virus (HIV) through its subsidiary. The company's products include OraSure, an oral specimen collection device and EPIblot, a serum-based Western blot confirmatory test kit. The prime customers of the company includes life insurance companies, prison systems, the military, and colleges and universities. The products are marketed in United States, Canada, Europe, Asia, Latin America and other countries. It is located in Beaverton, OR. | Health Technology |
TerraLUX, Inc.
TerraLUX, Inc. Electrical ProductsProducer Manufacturing TerraLUX, Inc. designs, patents and manufactures innovative LED based lighting products. It also designs and manufactures LED modules for lighting manufacturers, retailers, and designers. The firm's products include LED surface mount retrofit kits, down light retrofit kits and LEDSENSE intelligent controls. The company was founded by Anthony Catalano in 2003 and is headquartered in Longmont, CO. | Producer Manufacturing |
- Borsa valori
- Insiders
- Andrew S. Goldstein
